CORTANCYL 1 mg

DRUG4 trials

Sponsors

Centre Hospitalier Universitaire De Nantes, Centre Hospitalier Universitaire De Dijon, Hospices Civils De Lyon, Les Hopitaux Universitaires De Strasbourg

Conditions

GIant cell ArteritisPatients in remission for granulomatosis with polyangiitis (GPAWegener's) or microscopic polyangiitis (MPA) achieved with rituximab or cyclophosphamide or methotrexatekidney transplantkidney transplantation

Phase 2

Immunosuppression regimen reduction in kidney transplantation recipients admitted to the intensive care unit in the setting of septic shock and/or acute respiratory failure: an open multicentric randomized phase IV study

Not yet recruitingCTIS2024-518493-14-00

Les Hopitaux Universitaires De Strasbourgkidney transplant

Target: 212Updated: 2025-11-19

Phase 3

Prospective, multicenter, randomized, open-label, parallel-group controlled phase 3 study of tacrolimus minimization in kidney transplant recipients selected according to the AGORA algorithm for their low immunological risk and medium-term graft failure

RecruitingCTIS2022-502624-44-00

Centre Hospitalier Universitaire De Nanteskidney transplantation

Start: 2024-12-10Target: 343Updated: 2024-10-21

MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial

Active, not recruitingCTIS2024-512269-14-00

Centre Hospitalier Universitaire De DijonGIant cell Arteritis

Start: 2020-01-27Target: 230Updated: 2025-11-21

MAINEPSAN : A Prospective Comparative Randomized Double-blind Placebo-controlled In-Parallel Groups Multicenter, Study to Evaluate the remission MAINtenance using Extended administration of Prednisone in Systemic anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis.

RecruitingCTIS2024-514156-33-00

Hospices Civils De LyonPatients in remission for granulomatosis with polyangiitis (GPA, Wegener's) or microscopic polyangiitis (MPA) achieved with rituximab or cyclophosphamide or methotrexate

Start: 2019-08-20Target: 146Updated: 2025-12-19